Corpus Intelligence IC Memo — MERCY HOSPITAL ADA 2026-04-26 05:26 UTC
IC Memo — MERCY HOSPITAL ADA
Investment Committee Memorandum | OK | 108 beds | Grade C | EBITDA uplift $8.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERCY HOSPITAL ADA

CCN 370020 | PONTOTOC, OK | 108 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MERCY HOSPITAL ADA is a 108-bed suburban community hospital in PONTOTOC, OK with $109.6M in net patient revenue and a -2.6% operating margin. The hospital serves a payer mix of 39.1% Medicare, 21.6% Medicaid, and 39.3% commercial.

Thesis: Undervalued. Our ML models identify $8.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.6% to 4.7% (+736bps).

Net Revenue HCRIS$109.6M
Current EBITDA COMPUTED$-2.9M
Operating Margin COMPUTED-2.6%
Occupancy HCRIS36.5%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS26.5%
Distress Probability ML56.0%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
38
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -2.6% places it above the state median. Among 38 size-comparable peers (54-216 beds), the median margin is -3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (54-216), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERCY HOSPITAL ADA (Target)OK108$109.6M-2.6%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
COMANCHE COUNTY MEMORIAL HOSPIOK201$304.2M-7.9%
INTEGRIS SOUTHWEST MEDICAL CENOK169$267.6M-13.5%
HILLCREST HOSPITAL SOUTHOK152$218.9M4.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$70K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.3M
Clean Claim Rate
$70K
Total EBITDA Uplift$8.1M
Current EBITDA$-2.9M
+ RCM Uplift+$8.1M
Pro Forma EBITDA$5.2M
Current Margin-2.6%
Pro Forma Margin4.7%
WC Released (1x)$4.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.4M$61.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.4M$66.5M0.00x-100.0%
Bull Case9.0x11.0x$-4.0M$91.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.0M$98.9M0.00x-100.0%
Bear Case11.0x10.0x$-4.8M$22.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.8M$23.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 56.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 54-216 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-16.8% / P50=-3.8% / P75=7.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.